Tilidine hydrochloride in the treatment of 33 patients with moderate to severe cancer pain
-
摘要: 目的：评价盐酸替利定治疗中重度癌痛的疗效及安全性。方法：选择33例癌症患者,随机分为试验组18例和对照组15例。对照组用硫酸吗啡片20 mg,每日4次;试验组用盐酸替利定100 mg,每日4次,均连用5d。用数字评分法评估疼痛程度,记录疼痛变化及不良反应。同时在用药前及第6天做血常规、尿常规、肝肾功能和心电图检查。治疗结束后分别对症状、体征及实验室检查进行安全性和有效性评估。结果:2组服药前NRS评分差异无统计学意义(P0.05)。2组服药后第2~5天的NRS评分均较服药前明显降低(P0.01);服药后第2~5天,2组NRS评分差异均无统计学意义(P0.05)。癌痛有效率试验组为77.8%,对照组为73.3%,差异无统计学意义(P0.05);不良反应发生率分别为33.3%、40.0%,差异无统计学意义(P0.05)。结论：盐酸替利定和硫酸吗啡控制癌痛疗效和不良反应相似,可作为中重度癌痛的一线治疗。Abstract: Objective: To evaluate the safety and efficacy of tilidine hydrochloride in the treatment of moderate Objective: To severe cancer pain.Methods: Thirty-three cancer patients were randomly divided inObjective: To experimental group(18 cases) and control group(15 cases). Theexperimental group and control group were treated with 100 mg tilidine hydrochloride and 20 mg morphine sulfate 4 times daily for 5 days， espectively. The intensity of pain and adverse reactions were observed by numeral rating scale(NRS). The blood and urine routine， electrocardiogram and hepatic and nephritic function were detected at baseline and the sixth day. The signs and sympObjective: Toms and efficacy and safety of laboraObjective: Tory examination of two groups were evaluated at the end of treatment.Results: The NRS score of experimental group was 7. 28 1. 32 before tratment. On the No. 2nd，3rd，4 th and 5th days of treatment， the scores were 4. 94 1. 02，4. 00 0. 99，3. 67 0. 75 and 3. 22 0. 56， respectively. Compared with before treatment， the mean pain scores of two group were obviously improved after treatment，but the differences were not statistical significance(P ＞ 0. 05). The effective and adverse reaction rates of the experimental group and control group were 77. 8% 73. 3% and 33. 3% 40%， respectively， the differences of two group had no statistical significance (P ＞ 0. 05 ). Conclusions: The efficacy for controling cancer pain and adverse reactions of tilidine hydrochloride and morphine sulfate are similar，which can act as first-line treatment for moderate Objective: To severe cancer pain.
-
Keywords:
- cancer /
- pain /
- tilidine hydrochloride /
- morphine sulfate
-
-
[1] 李小梅，刘瑞琪，李红英，等.恶性肿瘤患者临终前的阿片类药物止痛回顾[J].中国肿瘤临床，2005，32(23) : 1358 - 1363. [1] [2] 徐建国.慢性疼痛的药物治疗进展[J].医学研究生学报，2007，20(2) : 113 - 119. [2] [3] Cleeland CS，Gonin R，Hatfield AK， et al.Pain and its treatment in out patients with metastatic cancer[J].N Engl J Med，1994，330(9) : 592 - 596.
[3] [4] Lotsch J.Opioid metabolites[J].J Pain Symptom Anage，2005，29(5 Suppl) : S10 - S24.
[4] [5] Jasinski DR，Preston KL.Evaluation of tilidine for morphine-like subjects and euphoria[J].Drug Alcohol Depend，1986，18 (3) :273 - 292.
[5] [6] Thierry C，Boeynaems JM，Paolo M.Actions of tilidine and nortilidine on cloned opioid receptors[J].Eur J Pharmacol，2005，506(3) : 205 - 208.
[6] [7] 陈素青，黄新洁，崔艳英，等.盐酸替利定的依赖性评价[J].中国药物依赖性杂志，2006，15(5) : 363 - 366. [7] [10] Zhang ZZ，Gong YY，Shi YH， et al.Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush[J].Neuroscience，2012，224(8) : 282 - 293.
[8] [11] Soni CR， Johnson LN.Visual neuropraxia and progressive vision loss from thyroid-associated stretch optic neuropathy[J].Eur JOphthalmol，2010，20(2) : 429 - 436.
[9] [12] Ma K，Xu L，Zhan H， et al.Dosage dependence of the effect ofGinkgo biloba on the rat retinal ganglion cell survival after optic nerve crush[J].Eye(Lond),2009，23(7) : 1598 - 1604.
[10] [13] Schmued LC，Fallon JH.Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties[J].Brain Res，1986，377(1) : 147 - 154.
[11] [14] Chiu K，Lau WM，Yeung SC， et al.Retrograde labeling of retinal ganglion cells by application of fluoro-gold on the surface of superior colliculus[J].J Vis Exp，2008，3791(16) : 819 - 820.
计量
- 文章访问数: 3350
- HTML全文浏览量: 398
- PDF下载量: 124
下载:
